Učitavanje...
Immuno-genomic analysis of exceptional responder to ALT-803 (IL-15 analogue) in BCG unresponsive non-muscle invasive bladder cancer: a case series and review of the literature
The clinical validity and utility of complex biomarkers have not been extensively studied in bladder cancer. Three patients with NMIBC (one patient with an exceptional response; CR for 30 months) who failed intravesical BCG were evaluated using a NYS CLEP approved assay, Immune Report Card, which me...
Spremljeno u:
| Izdano u: | J Immunother |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6783344/ https://ncbi.nlm.nih.gov/pubmed/31107371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000269 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|